173 related articles for article (PubMed ID: 2574191)
21. Nadolol as a treatment for akathisia.
Ratey JJ; Sorgi P; Polakoff S
Am J Psychiatry; 1985 May; 142(5):640-2. PubMed ID: 2858984
[TBL] [Abstract][Full Text] [Related]
22. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
[TBL] [Abstract][Full Text] [Related]
23. Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study.
Lerner V; Bergman J; Statsenko N; Miodownik C
J Clin Psychiatry; 2004 Nov; 65(11):1550-4. PubMed ID: 15554771
[TBL] [Abstract][Full Text] [Related]
24. Sodium valproate and biperiden in neuroleptic-induced akathisia, parkinsonism and hyperkinesia. A double-blind cross-over study with placebo.
Friis T; Christensen TR; Gerlach J
Acta Psychiatr Scand; 1983 Mar; 67(3):178-87. PubMed ID: 6134430
[No Abstract] [Full Text] [Related]
25. Propranolol in the treatment of neuroleptic-induced akathisia.
Lipinski JF; Zubenko GS; Cohen BM; Barreira PJ
Am J Psychiatry; 1984 Mar; 141(3):412-5. PubMed ID: 6142657
[TBL] [Abstract][Full Text] [Related]
26. Randomized, double-blind, crossover, placebo-controlled comparison of propranolol and betaxolol in the treatment of neuroleptic-induced akathisia.
Dumon JP; Catteau J; Lanvin F; Dupuis BA
Am J Psychiatry; 1992 May; 149(5):647-50. PubMed ID: 1349458
[TBL] [Abstract][Full Text] [Related]
27. Effects of a specific beta 2-receptor blocker in neuroleptic-induced akathisia.
Adler L; Duncan E; Angrist B; Hemdal P; Rotrosen J; Slotnick V
Psychiatry Res; 1989 Jan; 27(1):1-4. PubMed ID: 2564208
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of neuroleptic-induced akathisia with baclofen and clonazepam. A case report.
Sandyk R
Eur Neurol; 1985; 24(4):286-8. PubMed ID: 4006997
[TBL] [Abstract][Full Text] [Related]
29. Cyproheptadine treatment in neuroleptic-induced akathisia.
Weiss D; Aizenberg D; Hermesh H; Zemishlany Z; Munitz H; Radwan M; Weizman A
Br J Psychiatry; 1995 Oct; 167(4):483-6. PubMed ID: 8829717
[TBL] [Abstract][Full Text] [Related]
30. A placebo-controlled trial of nadolol in the treatment of neuroleptic-induced akathisia.
Wells BG; Cold JA; Marken PA; Brown CS; Chu CC; Johnson RP; Nasdahl CS; Ayubi MA; Knott DH; Arheart KL
J Clin Psychiatry; 1991 Jun; 52(6):255-60. PubMed ID: 1676029
[TBL] [Abstract][Full Text] [Related]
31. Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.
Thaker GK; Nguyen JA; Strauss ME; Jacobson R; Kaup BA; Tamminga CA
Am J Psychiatry; 1990 Apr; 147(4):445-51. PubMed ID: 1969244
[TBL] [Abstract][Full Text] [Related]
32. Intravenous diazepam in the treatment of neuroleptic-induced acute dystonia and akathisia.
Gagrat D; Hamilton J; Belmaker RH
Am J Psychiatry; 1978 Oct; 135(10):1232-3. PubMed ID: 29498
[No Abstract] [Full Text] [Related]
33. Pharmacological characterization of tardive akathisia.
Sachdev P; Chee KY
Biol Psychiatry; 1990 Nov; 28(9):809-18. PubMed ID: 1979500
[TBL] [Abstract][Full Text] [Related]
34. Akathisia, pseudoakathisia and tardive dyskinesia: clinical examples.
Munetz MR; Cornes CL
Compr Psychiatry; 1982; 23(4):345-52. PubMed ID: 6126315
[No Abstract] [Full Text] [Related]
35. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
Levin H; Chengappa KN; Kambhampati RK; Mahdavi N; Ganguli R
J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492
[TBL] [Abstract][Full Text] [Related]
36. Successful propranolol therapy for neuroleptic-induced akathisia resistant to anticholinergic and benzodiazepine drugs.
Hermesh H; Molcho A; Munitz H
Clin Neuropharmacol; 1988 Aug; 11(4):369-72. PubMed ID: 2905207
[No Abstract] [Full Text] [Related]
37. Clonazepam and phenobarbital in tardive dyskinesia.
Bobruff A; Gardos G; Tarsy D; Rapkin RM; Cole JO; Moore P
Am J Psychiatry; 1981 Feb; 138(2):189-93. PubMed ID: 6109454
[TBL] [Abstract][Full Text] [Related]
38. Beta-adrenergic antagonists in psychosis: is improvement due to treatment of neuroleptic-induced akathisia?
Lipinski JF; Keck PE; McElroy SL
J Clin Psychopharmacol; 1988 Dec; 8(6):409-16. PubMed ID: 2906947
[TBL] [Abstract][Full Text] [Related]
39. Effects of clozapine on treatment-resistant akathisia and concomitant tardive dyskinesia.
Wirshing WC; Phelan CK; van Putten T; Marder SR; Engel J
J Clin Psychopharmacol; 1990 Oct; 10(5):371-3. PubMed ID: 1979566
[No Abstract] [Full Text] [Related]
40. Emerging uses for high-potency benzodiazepines in psychotic disorders.
Bodkin JA
J Clin Psychiatry; 1990 May; 51 Suppl():41-6; discussion 50-3. PubMed ID: 1970817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
